A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)

CDKN2A is the major melanoma susceptibility gene so far identified, but only 40% of three or more case families have identified mutations. A comparison of mutation detection rates was carried out by “blind” exchange of samples across GenoMEL, the Melanoma Genetics Consortium, to establish the false...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Harland, Mark, Goldstein, Alisa M, Kukalizch, Kairen, Taylor, Claire, Hogg, David, Puig, Susana, Badenas, Celia, Gruis, Nelleke, Huurne, Jeanet ter, Bergman, Wilma, Hayward, Nicholas K, Stark, Mitchell, Tsao, Hensin, Tucker, Margaret A., Landi, Maria Teresa, Scarra, Giovanna Bianchi, Ghiorzo, Paola, Kanetsky, Peter A., Elder, David, Mann, Graham J, Holland, Elizabeth A, Bishop, D Timothy, Bishop, Julia Newton
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2494985/
https://ncbi.nlm.nih.gov/pubmed/18394881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2008.03.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars